Clinical pharmacists involvement in consultation: analysis and experience of 141 cases of infectious disease

ZHANG Jinping; ZHANG Haixia; XU Hang; BIAN Xiaojie; YANG Xian; FANG Yun

doi:10.3969/j.issn.1006-0111.2017.01.023

Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name

E-mail

Phone

Title

Content

Verification Code

Objective To investigate how the clinical pharmacists participate in the regime design and adjustment in the treatment of infectious disease and to show how clinical pharmacists to team with physicians for patient's infection control by contributing their special knowledge. Method From August 2012 to April 2014, 141 patients were consulted by the clinical pharmacists for the infectious diseases. The patient's basic information, ward distribution, consultation purpose, etiology of infections and adoption of the suggestions were analyzed. Results Among 141 consulted cases, most patients belonged to the urology, hepatobiliary surgery and neurosurgery department (accounted for 26.95%, 21.99% and 17.73% respectively). The top three consultation subjects are the use of ‘special use class’ antimicrobials, regime adjustment and medication choice (accounted for 85.82%, 74.62% and 59.57%). 133 suggestions from clinical pharmacists were accepted, 1 was partially adopted and 7 were rejected (accounted for 94.33%, 0.71% and 4.96%). Conclusion The clinical pharmacists play important roles in the treatment of infectious disease by providing the consultations to clinicians. With their special knowledge, clinical pharmacists can make a good contribution to ensure the safe and effective drug therapies.

Clinical pharmacists involvement in consultation: analysis and experience of 141 cases of infectious disease

Nanjing Drum Tower Hospital Affiliated to Medical College of Nanjing University, Pharmacy Department, Nanjing 210008, China

Received Date: 2016-03-12

Rev Recd Date: 2016-10-20

Key words:

Abstract: Objective To investigate how the clinical pharmacists participate in the regime design and adjustment in the treatment of infectious disease and to show how clinical pharmacists to team with physicians for patient's infection control by contributing their special knowledge. Method From August 2012 to April 2014, 141 patients were consulted by the clinical pharmacists for the infectious diseases. The patient's basic information, ward distribution, consultation purpose, etiology of infections and adoption of the suggestions were analyzed. Results Among 141 consulted cases, most patients belonged to the urology, hepatobiliary surgery and neurosurgery department (accounted for 26.95%, 21.99% and 17.73% respectively). The top three consultation subjects are the use of ‘special use class’ antimicrobials, regime adjustment and medication choice (accounted for 85.82%, 74.62% and 59.57%). 133 suggestions from clinical pharmacists were accepted, 1 was partially adopted and 7 were rejected (accounted for 94.33%, 0.71% and 4.96%). Conclusion The clinical pharmacists play important roles in the treatment of infectious disease by providing the consultations to clinicians. With their special knowledge, clinical pharmacists can make a good contribution to ensure the safe and effective drug therapies.

HTML

Reference (20)

[1]	陆赛花,吴玮峰,刘秀凤,等.临床药师在呼吸科参与抗菌药物使用的体会[J].中国医院药学杂志,2012,32(8):645-646.
[2]	李雪芹,李云景,卢荣枝,等.临床药师参与317例细菌感染性病例会诊分析[J].中国药物应用与监测,2012,9(3):150-152.
[3]	张波,冯雷,梅丹. 临床药师参与会诊的实践和分析[J].中国医院药学杂志,2014,34(2):148-151.
[4]	Quantrill S, Webbe D. Including pharmacists on consultant-led ward rounds[J]. Clin Med, 2011,11(6):627-628.
[5]	丁伯君,邓艳春,文娟.左乙拉西坦添加治疗难治性癫痫的疗效和安全性分析[J].中国临床神经科学,2011,19(2):189-191,198.
[6]	袁展望,李武平,刘冰,等.预防留置导尿管相关感染研究进展[J]. 中国感染控制杂志,2013,12(5):397-399.
[7]	陈晓华,李武平,刘冰,等.泌尿系统感染现状及防治研究进展[J].解放军护理杂志,2015,32(16):38-42,45.
[8]	Sarmiento JM, Dockrell DH, Schwab TR,et al. Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients[J]. Clin Transplant, 2000,14(2):136-138.
[9]	Kupeli E, Ulubay G, Golak T, et al. Pulmonary complications in renal recipients after transplantation[J]. Transplant Proc,2011,43(2):551-553.
[10]	孙斌,汪泽厚,姚志勇,等. 肾移植术后肺部感染患者免疫抑制剂的调整[J]. 空军总医院学报,2007,23(3):152-156.
[11]	Nose K, Oki T, Banno E, et al. Cytomegalovirus infection after prophylactic valganciclovir therapy postkidney transplantation:case reports[J]. Transplant Proc,2012,44(1):296-298.
[12]	Goto N, Oka S. Pneumocystis jirovecii pneumonia in kidney transplantation[J]. Transpl Infect Dis,2011,13(6):551-558.
[13]	Alangaden GJ, Thyagarajan R, Gruber SA, et al. Infectious complications after kidney transplantation:current epidemiology and associated risk factors[J]. Clin Transplant, 2006,20(4):401-409.
[14]	Dantas SR, Kuboyama RH, Mazzali M, et al. Nosocomial infections in renal transplant patients:risk factors and treatment implications associated with urinary tract and surgical site infections[J]. J Hosp Infect, 2006, 63(2):117-123.
[15]	Rubin RH, Wolfson JS, Cosimi AB, et al. Infection in the renal transplant recipient[J]. Am J Med,1981,70(2):405-411.
[16]	郭代红,陈超,李罄,等. 6所医院414例利奈唑胺相关性血小板减少集中监测研究[J].药物流行病学杂志,2013,22(3):109-113.
[17]	Chen C, Guo DH, Cao XT, et al. Risk factors for thrombocytopenia in adult Chinese receiving linezolid therapy[J]. Curr Ther Res Clin Exp, 2012,73(6):195-206.
[18]	Matsumoto K, Takeda Y, Takeshita A, et al. Renal function as a predictor of linezolid-induced thrombocytopenia[J].Int J Antimicrob Agents,2009,36(2):179-181.
[19]	Matsumoto K, Takeshita A, Ikawa K, et al. Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction[J]. Int J Antimrcro Agents,2009,33(1):98-99.
[20]	Brier ME, Stalker DJ, Aronoff GR, et al. Pharmacokinetics of linezolid in subjects with renal dysfunction[J]. Antimicrob Agents Chemother, 2003,47(9):2775-2780.

Message Board

Clinical pharmacists involvement in consultation: analysis and experience of 141 cases of infectious disease

doi: 10.3969/j.issn.1006-0111.2017.01.023

Abstract

References

Proportional views

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Related

Proportional views